Last Updated: Sunday, January 05, 2014, 13:24
UK-based drug major GlaxoSmithKline is knocking at the FIPB's doors to raise stake in its India arm by acquiring an additional 24.33 percent for around Rs 6,400 crore.
Last Updated: Wednesday, December 25, 2013, 12:16
Unilever, GlaxoSmithKline and PepsiCo made big bang announcements during the year as they decided to enhance their play in the "strategic and emerging" Indian market.
Last Updated: Monday, December 16, 2013, 18:38
At the NSE, the stock shot-up by 18.90 percent to close the trade at Rs 2,925.
Last Updated: Monday, December 16, 2013, 12:33
Shares of GlaxoSmithkline Pharmaceuticals today skyrocketed by 20 percent after UK-based GlaxoSmithKline Plc announced a voluntary open offer to increase stake in its Indian subsidiary.
Last Updated: Monday, December 16, 2013, 09:30
GlaxoSmithKline Plc (GSK) is looking at hiking stake in GlaxoSmithKline Pharmaceuticals to up to 75 percent from 50.67 percent, in line with FMCG giant Unilever increasing stake in its Indian arm HUL earlier this year.
Last Updated: Monday, November 11, 2013, 13:40
Drug firm GlaxoSmithKline Pharmaceuticals (GSK) on Monday reported 33.73 percent decline in standalone net profit at Rs 100.95 crore for the third quarter ended September 30, 2013.
Last Updated: Wednesday, November 06, 2013, 16:01
GlaxoSmithKline (GSK) Consumer Healthcare Ltd reported 14.29 per cent increase in standalone net profit at Rs 146.93 crore for the third quarter ended September 30, aided by higher sales.
Last Updated: Wednesday, October 23, 2013, 18:36
British pharmaceuticals giant GlaxoSmithKline announced on Wednesday a drop in quarterly net profits, while sales slumped in China where the group has been rocked by a state bribery probe.
Last Updated: Monday, September 09, 2013, 22:07
Japanese drinks giant Suntory said Monday it would buy the top-selling Lucozade and Ribena brands from British drugs firm GlaxoSmithKline (GSK) for USD 2.1 billion.
Last Updated: Friday, August 02, 2013, 12:41
The Intellectual Property Appellate Board (IPAB) has revoked the patent granted to the British drug major GlaxoSmithKline Pharma for its breast cancer drug -- Tykerb.
Last Updated: Wednesday, July 24, 2013, 19:07
GlaxoSmithKline expects its financial performance in China to take a hit from Beijing's probe into bribery allegedly carried out by senior staff, the British pharmaceuticals company said Wednesday.
Last Updated: Tuesday, July 23, 2013, 17:39
GlaxoSmithKline (GSK) has acknowledged that some senior employees in the firm were allegedly involved in a bribing scandal of doctors prescribing the firm's drugs in China.
more videos >>